STRATA Net Current Asset Value from 2010 to 2025

SSKN Stock  USD 2.72  0.05  1.81%   
STRATA Skin Net Current Asset Value yearly trend continues to be very stable with very little volatility. Net Current Asset Value is likely to drop to 0.00. At this time, STRATA Skin's Other Operating Expenses is very stable compared to the past year. As of the 7th of February 2025, Depreciation And Amortization is likely to grow to about 7.1 M, while Total Revenue is likely to drop about 19.5 M. . View All Fundamentals
 
Net Current Asset Value  
First Reported
2010-12-31
Previous Quarter
0.0
Current Value
0.0
Quarterly Volatility
0.0
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check STRATA Skin financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among STRATA Skin's main balance sheet or income statement drivers, such as Total Revenue of 19.5 M, Gross Profit of 11.1 M or Other Operating Expenses of 47.9 M, as well as many indicators such as Price To Sales Ratio of 0.63, Dividend Yield of 0.0 or PTB Ratio of 1.43. STRATA financial statements analysis is a perfect complement when working with STRATA Skin Valuation or Volatility modules.
  
Check out the analysis of STRATA Skin Correlation against competitors.
When determining whether STRATA Skin Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of STRATA Skin's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Strata Skin Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Strata Skin Sciences Stock:
Check out the analysis of STRATA Skin Correlation against competitors.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.60)
Revenue Per Share
9.347
Quarterly Revenue Growth
0.022
Return On Assets
(0.07)
Return On Equity
(0.63)
The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.